BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced scheduled oral and poster presentations at the 2014 American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 6 - 9, 2014, in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
